ASAN FOUNDATION
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1989-06-23
- Employees
- 501
- Market Cap
- -
- Website
- https://ails.amc.seoul.kr
Distribution of Helicobacter Pylori After Gastrectomy
- Conditions
- Helicobacter Pylori Infections
- Interventions
- Diagnostic Test: Endoscopic biopsy
- First Posted Date
- 2018-02-05
- Last Posted Date
- 2018-02-05
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT03419936
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Songpa-gu, Korea, Republic of
Preemptive Analgesic Effects of Popliteal Sciatic Nerve Block in Patients With Bilateral Hallux Valgus Surgery
Not Applicable
- Conditions
- Acute PainPreemptive Peripheral Nerve BlockPain, Postoperative
- Interventions
- Drug: Ultrasound guided popliteal sciatic nerve block with 0.2% ropivcaine
- First Posted Date
- 2018-01-30
- Last Posted Date
- 2018-01-30
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT03414593
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Songpa-gu, Korea, Republic of
Preemptive Analgesic Effects of Rectus Sheath Block in Laparoscopic Cholecystectomy Patients
Not Applicable
Completed
- Conditions
- Preemptive Peripheral Nerve BlockPain, PostoperativeAcute Pain
- Interventions
- Drug: Ultrasound guided Rectus sheath blockDrug: Intercostal nerve block
- First Posted Date
- 2018-01-29
- Last Posted Date
- 2019-01-23
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT03413280
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Songpa-gu, Korea, Republic of
Abbreviated 3 Cycles of Rituximab Plus CHOP(Cyclophosphamide, Adriamycin, Vincristine, and Prednisolone) Immunochemotherapy in Patients With Completely Excised LocalizedGastrointestinal CD(Cluster of Differentiation Antigen)20(+) Diffuse Large B-cell Lymphoma
Phase 2
- Conditions
- Diffuse Large B-cell Lymphoma
- Interventions
- Drug: Abb-R-CHOP
- First Posted Date
- 2018-01-16
- Last Posted Date
- 2018-01-16
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 36
- Registration Number
- NCT03399747
TAGRISSO (Osimertinib) in NSCLC Patients in Whom T790 Mutations Are Detected by Liquid Biopsy
- First Posted Date
- 2018-01-09
- Last Posted Date
- 2021-04-27
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 63
- Registration Number
- NCT03394118
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Intrapleural Docetaxel Administration Using Medical Pleuroscopy in Malignant Effusion With Lung Cancer
Phase 2
Completed
- Conditions
- Pleural Effusion, MalignantNon-small Cell Carcinoma
- Interventions
- First Posted Date
- 2018-01-09
- Last Posted Date
- 2019-03-08
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 4
- Registration Number
- NCT03394105
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Effect of PEEP on Arterial Oxygen Partial Pressure in Elderly Patients With Lithotomy Position Using LMA Supreme™
Not Applicable
Completed
- Conditions
- Urinary Bladder NeoplasmsProstatic Neoplasms
- Interventions
- Other: PEEP
- First Posted Date
- 2018-01-04
- Last Posted Date
- 2018-04-06
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 68
- Registration Number
- NCT03390127
- Locations
- 🇰🇷
Asan medical center, Seoul, Korea, Republic of
The Effect of Remote Ischemic Preconditioning in Living Donor Hepatectomy
Not Applicable
Completed
- Conditions
- Liver TransplantationIschemia Reperfusion InjuryTissue Donors
- Interventions
- Procedure: remote ischemic preconditioning
- First Posted Date
- 2017-12-29
- Last Posted Date
- 2019-08-19
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 160
- Registration Number
- NCT03386435
- Locations
- 🇰🇷
Asan medical center, Seoul, Songpa-gu, Korea, Republic of
A Phase II Trial of Ifosfamide, Etoposide, Cytarabine, and Methotrexate (IVAM) Chemotherapy for Refractory or Relapsed Diffuse Large B Cell Lymphoma
Phase 2
- Conditions
- Diffuse Large B Cell Lymphoma
- Interventions
- Drug: Ifosfamide, Etoposide, Cytarabine, and Methotrexate (IVAM) Chemotherapy
- First Posted Date
- 2017-12-26
- Last Posted Date
- 2017-12-26
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT03383406
Haploidentical NK Cells After Pemetrexed in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)
Phase 1
Completed
- Conditions
- Non-small Cell Lung Cancer
- Interventions
- Biological: Pemetrexed and donor-derived NK cell infusion
- First Posted Date
- 2017-12-08
- Last Posted Date
- 2019-07-08
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 5
- Registration Number
- NCT03366064
- Locations
- 🇰🇷
Asan Medical Center - University of Ulsan College of Medicine, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath